[…]working in the OTP is often the first medical provider with whom these patients establish a long-term therapeutic relationship so the OTP physician can be an important, even lifesaving, resource for patients enrolled in treatment, identifying the multiple medical problems that characterize chemical dependence and providing treatment or referrals to address these problems, said co-editor Deborah Stephenson, MD, MPH. When utilized by OTP physicians, the Guidelines serve to improve community safety and public health. A copy of the updated Guidelines can be downloaded for free at [PDF download]. Qualified OTP clinicians may request a free print copy of the Guidelines by […]
[…]article about these bills that appeared on 9/18/2019 in the Orange County Register CSAMās co-sponsored bill, AB-920 (Petrie-Norris), is on the Governorās desk to sign. This bill would require outpatient centers, which are now unsupervised by the state, to be licensed, regulated, and to adopt treatment criteria set by ASAM as the minimum standard of care. Also on the Governorās desk: AB-919 (Petrie-Norris) – would crack down on financial conflicts-of-interest among rehab operators SB-589 (Bates) – would prohibit rehabs and sober homes from making false or misleading advertising statements AB-290 (Wood) – would remove the financial incentive for treatment providers to lure people to California by promising […]
[…]visit the CSAM Education center to watch the new MAT webinars: Real Cases of Buprenorphine-Naloxone Treatment: What to do and how to do it? featuring CSAM members, Soraya Azari, MD, Kenneth Saffier, MD, FASAM and Scott Steiger, MD, FACP, FASAM. Transdermal Buprenorphine for Induction of Patients with Co-Morbid Pain featuring CSAM members, Soraya Azari, MD and Tauheed Zaman, MD. These webinars are FREE for CSAM members. These are two 2019 webinars on Medication Assisted Treatment (MAT) in primary care settings created by the California Society of Addiction Medicine (CSAM) with the support of a grant from the California Department of Healthcare Services (DHCS). We hope you enjoy the […]
[…]Assistance Programs, juvenile justice interventions, emergency room presentations of cannabis-related urgencies/emergencies, rates of use, and the publicās perception of risk associated with cannabis use. B. Professional Research: What constitutes treatment and who gets it; complete separation of medical and recreational cannabis. C. Technical Research: Assessment of cannabis intoxication and driving risks, clinical effects of high-potency extracts and edible products Above Statement Issued October 12, 2015 CSAM Task Force on Cannabis: Itai Danovitch, MD, MBA (co-chair)Monika Koch, MD (co-chair)Seth Ammerman, MDPeter Banys, MD, MScAngella Barr, MDTimmen Cermak, MDIhor Galarnyk, MDRandolph Holmes, MDBrian Hurley, MD, MBACathy McDonald, MDMario San BartolomĆ©, Jr., MD, […]
[…]on addressing questions patients frequently ask their physicians about its use, and based on up-to-date science, suggest ways to improve physician-patient discussions about cannabis and apply them to a clinical setting. Presenter: Itai Danovitch, MD Dr. Danovitch is President of the California Society of Addiction Medicine, and Chair for the Department of Psychiatry and Director of Addiction Psychiatry at Cedars Sinai Medical Center. His research interests have focused on substance use disorders, particularly marijuana, as well as the integration of medical and mental health services. Educational Objectives Upon completion of this program, participants should be able to: Answer patientsā questions […]
[…]reported a 48 percent reduction in primary drug use, a 53 percent reduction in alcohol and drug-related medical visits, and an 80 percent reduction in criminal activity. (ONDCP, 2002; CSAT, 2000) Evidence-based treatment modalities exist and should guide treatment programs. 7. Youth Treatment must be Comprehensive. Substance dependence is a chronic medical condition requiring ongoing support and monitoring, especially with youth and young adults. As with other chronic conditions, treatment works, but does not cure. A statewide network of residential treatment centers should be established for those who are unable to be treated effectively in intensive outpatient programs. Treatment programs […]
[…]its plans.Ā 4. TREATMENT, NOT PRISONĀ Our courts and prisons are overburdened by nonviolent drug-related oā¢ā¢enders.Ā CSAM believes that the social disruptions caused by disease are best ameliorated by medical treatment.Ā Evidence proves that treatment is more effective in reducing recidivism and more economical than incarceration.Ā CSAM advocates annual (cost of living) budget increases for Proposition 36 (Substance Abuse and Crime Prevention Act, Public Initiative 2000).Ā CSAM opposes proposed 2007 state funding cuts to Prop 36 disguised as county matching plans.Ā CSAM supports stratiļ¬cation of courts and treatment providers, with clinical case management for high utilizers and drug courts for more […]
[…]Requires a least one randomized controlled trial (RCT) as part of the evidence B. Requires well-controlled clinical studies, but no RCT C. Requires clinical experience of respected authorities Other frameworks make finer distinctions among different levels of evidence (e.g., Oxford Centre for EBM Levels of Evidence), but the thrust of each is the same. The āgold standardā for credibility is met by randomized, double-blind, placebo-controlled trials, with multi-site studies being preferred to single-site studies. The unique advantage of randomization is that it enables researchers to evaluate whether the intervention (or product) itself, as opposed to other factors, causes any observed […]
